longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

Tactile

TCMD

----
Start trading
OverviewOverviewNewsNewsPostsPostsFinancialsFinancialsForecastForecastValuationValuationShareholdersShareholdersProfileProfile
LongbridgeAI

Current ValuationThe current P/E ratio is 20.31, within the reasonable range, cheaper than 43.93% of the time in the past 3 years, and the industry ranks 17/174, the industry Median -0.89.

20.31xP/E
$22.29Stock price
$1.10Earnings per share
20.31xP/E
Stock price$22.29Earnings per share$1.10

Historical Valuation

P/E ratioTypical rangeMedian
P/E ratio
19.17x
Typical range
11.54x–29.32x

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.
012243648

The industry median valuation is currently at or below 0 and may not serve as a meaningful benchmark.

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
0x30x60x90x120x150x
P/E ratio
Name/Symbol
MDTUSMedtronic
21.10x26.89%$110.38B
SYKUSStryker
28.33x53.09%$105.63B
BSXUSBoston Scientific
17.22x36.31%$63.26B
RMDUSResmed
20.94x11.53%$31.89B
PHGUSKoninklijke Philips Elect
18.46x16.23%$23.88B
RYLPFUSKoninklijke Philips N.V.
18.41x--$23.81B
TRUMYUSTerumo
20.20x--$21.23B
STEUSSteris
25.44x17.10%$20.48B
ZBHUSZimmer Biomet
21.00x37.01%$16.94B
SNNUSSmith and Nephew
17.86x42.74%$11.34B
GMEDUSGlobus Medical Inc
18.78x6.02%$10.06B
PODDUSInsulet
24.11x76.03%$9.05B
SSMXYUSSysmex
27.92x--$7.06B
LIVNUSLivanova
22.35x189.82%$4.21B
TMDXUSTransMedics
19.07x71.90%$2.89B
LMATUSLemaitre Vascular
28.73x13.99%$1.89B
CNMDUSConmed
24.51x156.95%$1.38B
TCMDUSTactile
20.31x36.59%$504.92M
BWAYUSBrainsway
27.38x70.37%$258.53M
ELMDUSElectromed
20.70x11.92%$233.94M

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.